Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
Pliant Therapeutics, a clinical-stage biotechnology company focused on integrin-based therapeutics, announced its participation in the RBC Capital Markets Global Healthcare Conference on May 19, 2026. The company's CEO and CFO will discuss their lead drug candidate PLN-101095, currently in Phase 1b trials targeting advanced or metastatic solid tumo…